A Study of Tirzepatide (LY3298176) in Adult Participants in India With Either Type 2 Diabetes Mellitus or Obesity
Clinical trial NCT07438444 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07438444
- Sponsor
- Eli Lilly and Company
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2026-02-27
- Primary completion
- 2027-07-01
- Enrollment
- 344
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.